Atossa Therapeutics, Inc.
ATOS
$2.40
-$0.12-4.57%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.31% | -42.88% | -36.33% | -12.15% | -10.84% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -5.88% | -40.74% | -38.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.54% | -32.46% | -34.00% | -22.11% | 107.17% |
| Change in Net Operating Assets | 1.32% | 1,337.93% | 423.66% | -72.96% | -118.30% |
| Cash from Operations | -42.97% | -49.76% | -41.52% | -34.39% | -33.91% |
| Capital Expenditure | 26.32% | 36.36% | -21.05% | 15.79% | -90.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 26.32% | 36.36% | -21.05% | 15.79% | -90.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.19% | -- | -- | 1,008.22% | 1,008.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.32% | -- | -- | 1,008.22% | 387.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.58% | -77.23% | -71.41% | -18.98% | -9.09% |